Most searched codes in this category
Monthly US Google searches for the bare code (Google Ads, measured October 9, 2026) show which codes in this category coders and billers look up most.
| Code | Short descriptor | Medicare amount | Searches / month |
|---|---|---|---|
| U0001 | 2019-ncov diagnostic p | $35.92 | 1,000 |
| P3000 | Screen Pap by tech w md supv | $18.54 | 720 |
| G0480 | Drug test def 1-7 classes | $114.43 | 590 |
| G0103 | PSA screening | $19.31 | 480 |
| G0481 | Drug test def 8-14 classes | $156.59 | 320 |
| U0002 | COVID-19 lab test non-cdc | $51.31 | 320 |
| P2033 | Blood thymol turbidity | $4.95 | 210 |
| P3001 | Screening Pap smear by phys | $24.05 | 140 |
| P9016 | Rbc leukocytes reduced | $184.91 | 140 |
| G0145 | Scr c/v cyto,thinlayer,rescr | $26.49 | 110 |
Codes in this category
37 codes in this category have an indexed reference page; the other 48 active codes follow as a list and keep their own pages for lookups. The Medicare amount is the national figure each code page leads with, and the range column links the HCPCS range hub the code also belongs to.
| Code | Descriptor | Medicare amount | Basis | Range hub |
|---|---|---|---|---|
| G0027 | Semen analysis; presence and/or motility of sperm excluding huhner | $6.50 | CLFS | G codes |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | $19.31 | CLFS | G codes |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | $20.26 | CLFS | G codes |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | $24.05 | PFS non-facility | G codes |
| G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician | $24.05 | PFS non-facility | G codes |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | $26.49 | CLFS | G codes |
| G0327 | Colorectal cancer screening; blood-based biomarker | — | none in these files | G codes |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | $18.05 | CLFS | G codes |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | $356.72 | PFS non-facility | G codes |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | $19.57 | CLFS | G codes |
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | $18.29 | CLFS | G codes |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | $114.43 | CLFS | G codes |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | $156.59 | CLFS | G codes |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | $28.27 | CLFS | G codes |
| G0659 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes | $62.14 | CLFS | G codes |
| P2028 | Cephalin floculation, blood | $4.95 | CLFS | P codes |
| P2029 | Congo red, blood | $4.95 | CLFS | P codes |
| P2033 | Thymol turbidity, blood | $4.95 | CLFS | P codes |
| P2038 | Mucoprotein, blood (seromucoid) (medical necessity procedure) | $4.95 | CLFS | P codes |
| P3000 | Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision | $18.54 | CLFS | P codes |
| P3001 | Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician | $24.05 | PFS non-facility | P codes |
| P9010 | Blood (whole), for transfusion, per unit | $189.84 | OPPS rate | P codes |
| P9011 | Blood, split unit | $155.84 | OPPS rate | P codes |
| P9016 | Red blood cells, leukocytes reduced, each unit | $184.91 | OPPS rate | P codes |
| P9020 | Platelet rich plasma, each unit | $559.79 | OPPS rate | P codes |
| P9021 | Red blood cells, each unit | $150.57 | OPPS rate | P codes |
| P9035 | Platelets, pheresis, leukocytes reduced, each unit | $511.59 | OPPS rate | P codes |
| P9037 | Platelets, pheresis, leukocytes reduced, irradiated, each unit | $680.61 | OPPS rate | P codes |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | $265.41 | OPPS rate | P codes |
| P9059 | Fresh frozen plasma between 8-24 hours of collection, each unit | $73.77 | OPPS rate | P codes |
| P9060 | Fresh frozen plasma, donor retested, each unit | $53.25 | OPPS rate | P codes |
| P9073 | Platelets, pheresis, pathogen-reduced, each unit | $607.43 | OPPS rate | P codes |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | $9.34 | CLFS | P codes |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | $18.54 | CLFS | Q codes for services and supplies (non-drug) |
| Q0112 | All potassium hydroxide (koh) preparations | $5.83 | CLFS | Q codes for services and supplies (non-drug) |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | $35.92 | CLFS | Other Level II codes |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | $51.31 | CLFS | Other Level II codes |
Show the other 48 codes (pages not in search results)
- A4250 Urine reagent strips/tablets
- A9275 Disp home glucose monitor
- C9507 COVID-19 convalescent plasma
- G0143 Scr c/v cyto,thinlayer,rescr
- G0144 Scr c/v cyto,thinlayer,rescr
- G0147 Scr c/v cyto, automated sys
- G0148 Scr c/v cyto, autosys, rescr
- G0306 Cbc/diffwbc w/o platelet
- G0307 Cbc without platelet
- G0435 Oral HIV-1/HIV-2 screen
- G0482 Drug test def 15-21 classes
- G0483 Drug test def 22+ classes
- G0567 Screening hep c detect
- P2031 Hair analysis
- P7001 Culture bacterial urine
- P9012 Cryoprecipitate each unit
- P9017 Plasma 1 donor frz w/in 8 hr
- P9019 Platelets, each unit
- P9022 Washed red blood cells unit
- P9023 Frozen plasma, pooled, sd
- P9025 Plasma cryo redu path each
- P9026 Cryo fib comp path redu each
- P9027 Rbc o2 co2 reduced
- P9031 Platelets leukocytes reduced
- P9032 Platelets, irradiated
- P9033 Platelets leukoreduced irrad
- P9034 Platelets, pheresis
- P9036 Platelet pheresis irradiated
- P9038 Rbc irradiated
- P9039 Rbc deglycerolized
- P9043 Plasma protein fract,5%,50ml
- P9044 Cryoprecipitatereducedplasma
- P9051 Blood, l/r, cmv-neg
- P9052 Platelets, hla-m, l/r, unit
- P9053 Plt, pher, l/r cmv-neg, irr
- P9054 Blood, l/r, froz/degly/wash
- P9055 Plt, aph/pher, l/r, cmv-neg
- P9056 Blood, l/r, irradiated
- P9057 Rbc, frz/deg/wsh, l/r, irrad
- P9058 Rbc, l/r, cmv-neg, irrad
- P9070 Pathogen reduced plasma pool
- P9071 Pathogen reduced plasma sing
- P9099 Blood component/product NOC
- P9100 Pathogen test for platelets
- P9615 Urine specimen collect mult
- Q0113 Pinworm examinations
- Q0114 Fern test
- Q0115 Post-coital mucous exam
How this category is built
HCPCS Level II codes are organized by their first letter, which is how the range hubs on this site group them, but one kind of item or service often spans several letters: wheelchairs sit in the E and K ranges, supplies in A, B, Q and T, and imaging in A, C, G, Q and R. This hub regroups the codes by the BETOS category CMS records for each code in the HCPCS file, splitting the large prosthetic and orthotic category by L-code range and keeping vision and hearing items apart, so each non-drug code belongs to exactly one category hub besides its range hub. The national Medicare amount comes from the 2026 physician fee schedule, DMEPOS, clinical laboratory, OPPS or ASC file that prices the code, as on its reference page.
Where QuickIntell fits for laboratory tests
QuickCode supports qualified coder review of units, modifiers and NCCI pairs before the claim leaves, and QuickAuth coordinates requirement checks and documentation for items and services that a coverage policy governs, each with human review.
Frequently asked questions
Which HCPCS codes are grouped under "Laboratory tests"?
85 active Level II codes in the October 2026 file, grouped here by BETOS T1 (laboratory tests). 37 have a full reference page; the table lists those and the collapsed list names the rest.
What is a BETOS category?
The Berenson-Eggers Type of Service classification groups HCPCS and CPT codes into broad clinical categories such as evaluation and management, procedures, imaging, tests and durable medical equipment. CMS carries a BETOS code for each Level II code in the HCPCS file, which is what this hub reads.
Which code in this category has the highest Medicare amount?
Among the codes with an indexed page, P9037 at $680.61 (OPPS rate), from the October 2026 files. Each code page shows the full breakdown by modifier, state or locality.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-10. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare PFS national relative value file RVU26D (non-QPP), October 2026Version RVU26D, released 2026-08-26 · effective 2026-10-01 · file PPRRVU2026_Oct_nonQPP.csvSHA-256 4d0d3f19bd954ffc…
- DMEPOS fee schedule DME26-D, October 2026Version DME26-D (October 2026) · effective 2026-10-01 · file DMEPOS_OCT.csvSHA-256 a2824d58aadf4004…
- Clinical Laboratory Fee Schedule public use file, 2026 fourth quarter (26CLABQ4)Version 26CLABQ4 (CY2026 Q4) · effective 2026-10-01 · file PUF_CLFS_CY2026_Q4V1.csvSHA-256 fcfec34526c44390…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
Disclaimer
Operational reference compiled from CMS publications. Amounts are Medicare national figures before locality and state adjustment; other payers differ. CPT codes appear as numbers only. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.